MENU
+Compare
EAPIF
Stock ticker: OTC
AS OF
Oct 20 closing price
Price
$3.59
Change
+$0.39 (+12.19%)
Capitalization
357.62M

EAPIF EUROAPI SA Forecast, Technical & Fundamental Analysis

Euroapi SA develops, manufactures, markets, and distributes Active Pharmaceutical Ingredients (APIs) and Intermediates used in the formulation of medicines for human and veterinary use, both from originators, generics, and cosmetics... Show more

EAPIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for EAPIF with price predictions
Nov 18, 2025

Aroon Indicator for EAPIF shows an upward move is likely

EAPIF's Aroon Indicator triggered a bullish signal on November 18, 2025. Tickeron's A.I.dvisor detected that the AroonUp green line is above 70 while the AroonDown red line is below 30. When the up indicator moves above 70 and the down indicator remains below 30, it is a sign that the stock could be setting up for a bullish move. Traders may want to buy the stock or look to buy calls options. A.I.dvisor looked at 65 similar instances where the Aroon Indicator showed a similar pattern. In of the 65 cases, the stock moved higher in the days that followed. This puts the odds of a move higher at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 10 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for EAPIF turned negative on November 06, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 16 similar instances when the indicator turned negative. In of the 16 cases the stock turned lower in the days that followed. This puts the odds of success at .

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. EAPIF’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.309) is normal, around the industry mean (18.491). P/E Ratio (7.918) is within average values for comparable stocks, (71.901). EAPIF's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.834). EAPIF has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.030). P/S Ratio (0.331) is also within normal values, averaging (55.234).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. EAPIF’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 90, placing this stock worse than average.

View a ticker or compare two or three
EAPIF
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

Industry PharmaceuticalsGeneric

Profile
Fundamentals
Details
Industry
N/A
Address
15 rue Traversiere
Phone
N/A
Employees
N/A
Web
https://www.euroapi.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
IPAYX11.100.04
+0.36%
Integrity Dividend Summit I
PIREX28.10N/A
N/A
Principal Real Estate Securities Inst
GCVUX25.15N/A
N/A
Goldman Sachs Large Cp Val Insghts R6
PSMKX59.72N/A
N/A
Victory Pioneer Select Mid Cap Growth R6
JSPIX29.55N/A
N/A
Jackson Square Large-Cap Growth Instl

EAPIF and Stocks

Correlation & Price change

A.I.dvisor tells us that EAPIF and HLN have been poorly correlated (+14% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that EAPIF and HLN's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
HLN - EAPIF
14%
Poorly correlated
-0.72%
HLNCF - EAPIF
11%
Poorly correlated
-1.04%
IXHL - EAPIF
7%
Poorly correlated
+3.09%
AKAN - EAPIF
2%
Poorly correlated
-0.48%
ALVO - EAPIF
2%
Poorly correlated
-0.78%
More

Groups containing EAPIF

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To EAPIF
1D Price
Change %
EAPIF100%
N/A
Pharmaceuticals: Generic
industry (214 stocks)
11%
Poorly correlated
+3.48%